Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Impact of heavy proteinuria on clinical outcomes in patients on incident peritoneal dialysis

Authors: Seok Hui Kang, Kyu Hyang Cho, Jong Won Park, Kyung Woo Yoon, Jun Young Do

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

There are few reports on the nutritional status changes and residual renal function (RRF) according to proteinuria levels in patients on peritoneal dialysis (PD).

Methods

A total of 388 patients on PD were enrolled. The patients were divided into 3 groups with respect to initial proteinuria: the A (n = 119; <500 mg/day), B (n = 218; 500–3,500 mg/day), and C groups (n = 51; >3,500 mg/day).

Results

The patients with higher proteinuria levels had a higher incidence of male sex, diabetes mellitus, and icodextrin use than those with lower proteinuria levels. Although initial peritoneal albumin loss in C group was lower than that detected in the other groups, no significant difference was observed in peritoneal albumin loss among the 3 groups at the end of follow-up period. At the time of PD initiation, the Geriatric nutritional risk index (GNRI) was lower in the C group than in the other 2 groups. However, at the end of the follow-up period, there was no significant difference in GNRI between the 3 groups. The GNRI increased, and the proteinuria level or RRF decreased more in the C group than in the other 2 groups. There were no significant differences in lean mass index or fat mass index change from the time of PD initiation to the end of the follow-up period. However, fat mass index and nPNA showed greater increases in the C group. The multivariate analysis revealed that proteinuria was negatively correlated with GNRI at the time of PD initiation and at the end of the follow-up period. The initial RRF and proteinuria were negatively correlated with the RRF decline during the follow-up.

Conclusion

The attenuation of the nephrotic proteinuria, along with the RRF decline, was associated with the improvement of the malnutrition.
Literature
1.
go back to reference Palmer BF: Proteinuria as a therapeutic target in patients with chronic kidney disease. Am J Nephrol. 2007, 27: 287-93. 10.1159/000101958.CrossRefPubMed Palmer BF: Proteinuria as a therapeutic target in patients with chronic kidney disease. Am J Nephrol. 2007, 27: 287-93. 10.1159/000101958.CrossRefPubMed
2.
go back to reference Kaysen GA: Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol. 1998, 9: 2368-76.PubMed Kaysen GA: Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol. 1998, 9: 2368-76.PubMed
3.
go back to reference Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001, 12: 2158-62.PubMed Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001, 12: 2158-62.PubMed
4.
go back to reference Paniagua R, Amato D, Vonesh E, et al: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002, 13: 1307-20.PubMed Paniagua R, Amato D, Vonesh E, et al: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002, 13: 1307-20.PubMed
5.
go back to reference Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 2003, 41: 1293-302. 10.1016/S0272-6386(03)00362-7.CrossRefPubMed Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 2003, 41: 1293-302. 10.1016/S0272-6386(03)00362-7.CrossRefPubMed
6.
go back to reference Marrón B, Remón C, Pérez-Fontán M, Quirós P, Ortíz A: Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int Suppl. 2008, 108: S42-51.CrossRefPubMed Marrón B, Remón C, Pérez-Fontán M, Quirós P, Ortíz A: Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int Suppl. 2008, 108: S42-51.CrossRefPubMed
7.
go back to reference Jansen MA, Hart AA, Korevarr JC, Dekker FW, Boeschoten EW, Krediet RT: NECOSAD Study Group. Predictors of the rate of residual renal function in incident dialysis patients. Kidney Int. 2002, 62: 1046-53. 10.1046/j.1523-1755.2002.00505.x.CrossRefPubMed Jansen MA, Hart AA, Korevarr JC, Dekker FW, Boeschoten EW, Krediet RT: NECOSAD Study Group. Predictors of the rate of residual renal function in incident dialysis patients. Kidney Int. 2002, 62: 1046-53. 10.1046/j.1523-1755.2002.00505.x.CrossRefPubMed
8.
go back to reference Mujais S, Nolph K, Gokal R, et al: Evaluation and management of ultrafiltration problems in peritoneal dialysis International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000, 20 (suppl 4): S5-21.PubMed Mujais S, Nolph K, Gokal R, et al: Evaluation and management of ultrafiltration problems in peritoneal dialysis International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000, 20 (suppl 4): S5-21.PubMed
9.
go back to reference Watson PE, Watson IE, Bratt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980, 33: 27-39.PubMed Watson PE, Watson IE, Bratt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980, 33: 27-39.PubMed
10.
go back to reference Bergstrom J, Heimburger O, Lindholm B: Calculation of the protein equivalent of total nitrogen appearance from urea appearance: what formulas should be used. Perit Dial Int. 1998, 18: 467-73.PubMed Bergstrom J, Heimburger O, Lindholm B: Calculation of the protein equivalent of total nitrogen appearance from urea appearance: what formulas should be used. Perit Dial Int. 1998, 18: 467-73.PubMed
11.
go back to reference Lorenz FH: Der Konstitutionsindex der Frau. Klin Wochenshr. 1929, 16: 734-6.CrossRef Lorenz FH: Der Konstitutionsindex der Frau. Klin Wochenshr. 1929, 16: 734-6.CrossRef
12.
go back to reference National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42 (S1): 201- National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42 (S1): 201-
13.
go back to reference Bouillanne O, Morineau G, Dupont C, et al: Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005, 82: 777-83.PubMed Bouillanne O, Morineau G, Dupont C, et al: Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005, 82: 777-83.PubMed
14.
go back to reference Kobayashi I, Ishimura E, Kato Y, et al: Geriatric nutritional risk index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients. Nephrol Dial Transplant. 2010, 25: 3361-5. 10.1093/ndt/gfq211.CrossRefPubMed Kobayashi I, Ishimura E, Kato Y, et al: Geriatric nutritional risk index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients. Nephrol Dial Transplant. 2010, 25: 3361-5. 10.1093/ndt/gfq211.CrossRefPubMed
15.
go back to reference Yamada K, Furuya R, Takita T, et al: Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr. 2008, 87: 106-13.PubMed Yamada K, Furuya R, Takita T, et al: Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr. 2008, 87: 106-13.PubMed
16.
go back to reference Peterson JC, Adler S, Burkart JM, et al: Blood pressure control, proteinuria, and the progression of renal disease, The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995, 123: 754-62.CrossRefPubMed Peterson JC, Adler S, Burkart JM, et al: Blood pressure control, proteinuria, and the progression of renal disease, The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995, 123: 754-62.CrossRefPubMed
17.
go back to reference Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG: Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int. 2000, 20: 429-38.PubMed Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG: Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int. 2000, 20: 429-38.PubMed
18.
go back to reference Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J: Are there two types of malnutrition in chronic renal failure? evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000, 15: 953-60. 10.1093/ndt/15.7.953.CrossRefPubMed Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J: Are there two types of malnutrition in chronic renal failure? evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000, 15: 953-60. 10.1093/ndt/15.7.953.CrossRefPubMed
19.
go back to reference Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB: Kindey Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis. 2004, 44: S39-46.CrossRef Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB: Kindey Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis. 2004, 44: S39-46.CrossRef
20.
go back to reference Heaf JG, Sarac S, Afzal S: A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant. 2005, 20: 2194-201. 10.1093/ndt/gfi008.CrossRefPubMed Heaf JG, Sarac S, Afzal S: A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant. 2005, 20: 2194-201. 10.1093/ndt/gfi008.CrossRefPubMed
21.
go back to reference Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L: Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron. 1986, 42: 133-40. 10.1159/000183652.CrossRefPubMed Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L: Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron. 1986, 42: 133-40. 10.1159/000183652.CrossRefPubMed
22.
go back to reference Balafa O, Halbesma N, Struijk DG, Dekker FW, Krediet RT: Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011, 6: 561-6. 10.2215/CJN.05540610.CrossRefPubMedPubMedCentral Balafa O, Halbesma N, Struijk DG, Dekker FW, Krediet RT: Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011, 6: 561-6. 10.2215/CJN.05540610.CrossRefPubMedPubMedCentral
23.
go back to reference Prinsen BH, Rabelink TJ, Beutler JJ, et al: Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure. Kidney Int. 2003, 64: 1495-504. 10.1046/j.1523-1755.2003.00211.x.CrossRefPubMed Prinsen BH, Rabelink TJ, Beutler JJ, et al: Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure. Kidney Int. 2003, 64: 1495-504. 10.1046/j.1523-1755.2003.00211.x.CrossRefPubMed
24.
go back to reference Wang AY, Sea MM, Ip R, et al: Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 2001, 12: 2450-7.PubMed Wang AY, Sea MM, Ip R, et al: Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 2001, 12: 2450-7.PubMed
25.
go back to reference Szeto CC, Lai KN, Wong TY, Law MC, Leung CB, Yu AW, Li PK: Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1999, 34: 1056-64. 10.1016/S0272-6386(99)70011-9.CrossRefPubMed Szeto CC, Lai KN, Wong TY, Law MC, Leung CB, Yu AW, Li PK: Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1999, 34: 1056-64. 10.1016/S0272-6386(99)70011-9.CrossRefPubMed
26.
go back to reference Wang AY, Woo J, Wang M, Sea MM, Sanderson JE, Lui SF, Li PK: Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant. 2005, 20: 396-403. 10.1093/ndt/gfh331.CrossRefPubMed Wang AY, Woo J, Wang M, Sea MM, Sanderson JE, Lui SF, Li PK: Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant. 2005, 20: 396-403. 10.1093/ndt/gfh331.CrossRefPubMed
27.
go back to reference Kaysen GA, Gambertoglio J, Jiminez I, Jones H, Hutchison FN: Effect of dietary protein intake on albumin homeostasis in nephrotic syndrome. Kidney Int. 1986, 29: 572-7. 10.1038/ki.1986.36.CrossRefPubMed Kaysen GA, Gambertoglio J, Jiminez I, Jones H, Hutchison FN: Effect of dietary protein intake on albumin homeostasis in nephrotic syndrome. Kidney Int. 1986, 29: 572-7. 10.1038/ki.1986.36.CrossRefPubMed
28.
go back to reference Kaysen GA, Schoenfeld PY: Albumin homeostasis in patients undergoing continuous peritoneal dialysis. Kidney Int. 1984, 25: 107-14. 10.1038/ki.1984.15.CrossRefPubMed Kaysen GA, Schoenfeld PY: Albumin homeostasis in patients undergoing continuous peritoneal dialysis. Kidney Int. 1984, 25: 107-14. 10.1038/ki.1984.15.CrossRefPubMed
29.
go back to reference Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Sheraton T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000, 11: 556-64.PubMed Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Sheraton T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000, 11: 556-64.PubMed
30.
go back to reference Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P: Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int. 2003, 23: 276-83.PubMed Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P: Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int. 2003, 23: 276-83.PubMed
31.
go back to reference Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis. 1999, 34: 14-20. 10.1016/S0272-6386(99)70102-2.CrossRefPubMed Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis. 1999, 34: 14-20. 10.1016/S0272-6386(99)70102-2.CrossRefPubMed
32.
go back to reference Baker RJ, Senior H, Clemenger M, Brown EA: Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis. 2003, 41: 670-5. 10.1053/ajkd.2003.50129.CrossRefPubMed Baker RJ, Senior H, Clemenger M, Brown EA: Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis. 2003, 41: 670-5. 10.1053/ajkd.2003.50129.CrossRefPubMed
33.
go back to reference Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville NC, Wiggins KJ, Bannister KM, Johnson DW: Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function. Nephrol Dial Transplant. 2012, 27: 381-7. 10.1093/ndt/gfr274.CrossRefPubMed Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville NC, Wiggins KJ, Bannister KM, Johnson DW: Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function. Nephrol Dial Transplant. 2012, 27: 381-7. 10.1093/ndt/gfr274.CrossRefPubMed
34.
go back to reference Jones CH, Newstead CG, Will EJ, Smye SW, Davison AM: Assessment of nutritional status in CAPD patients: serum albumin is not a useful measure. Nephrol Dial Transplant. 1997, 12: 1406-13. 10.1093/ndt/12.7.1406.CrossRefPubMed Jones CH, Newstead CG, Will EJ, Smye SW, Davison AM: Assessment of nutritional status in CAPD patients: serum albumin is not a useful measure. Nephrol Dial Transplant. 1997, 12: 1406-13. 10.1093/ndt/12.7.1406.CrossRefPubMed
Metadata
Title
Impact of heavy proteinuria on clinical outcomes in patients on incident peritoneal dialysis
Authors
Seok Hui Kang
Kyu Hyang Cho
Jong Won Park
Kyung Woo Yoon
Jun Young Do
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-171

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.